Cargando…
Systematic Identification of Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro
One of the key stages in the development of new therapies in the treatment of toxoplasmosis is the identification of new non-toxic small molecules with high specificity to Toxoplasma gondii. In the search for such structures, thiosemicarbazide-based compounds have emerged as a novel and promising le...
Autores principales: | Paneth, Agata, Węglińska, Lidia, Bekier, Adrian, Stefaniszyn, Edyta, Wujec, Monika, Trotsko, Nazar, Dzitko, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384730/ https://www.ncbi.nlm.nih.gov/pubmed/30744161 http://dx.doi.org/10.3390/molecules24030614 |
Ejemplares similares
-
Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro via Structure-Based Design
por: Paneth, Agata, et al.
Publicado: (2019) -
Synthesis and In Vitro Anti-Toxoplasma gondii Activity of Novel Thiazolidin-4-one Derivatives
por: Trotsko, Nazar, et al.
Publicado: (2019) -
Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine
por: Węglińska, Lidia, et al.
Publicado: (2022) -
4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents
por: Bekier, Adrian, et al.
Publicado: (2021) -
TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents
por: Dzitko, Katarzyna, et al.
Publicado: (2023)